259 related articles for article (PubMed ID: 8150756)
21. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
[TBL] [Abstract][Full Text] [Related]
22. [Resistance to penicillin and other antimicrobials in 103 clinical isolations of Streptococcus pneumoniae (2000-2001)].
García-Irure JJ; Navascués A; Martín I; Gastesi C
An Sist Sanit Navar; 2003; 26(1):27-33. PubMed ID: 12759709
[TBL] [Abstract][Full Text] [Related]
23. Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia.
Shibl AM; Al Rasheed AM; Elbashier AM; Osoba AO
J Chemother; 2000 Apr; 12(2):134-7. PubMed ID: 10789552
[TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.
Vanhoof R; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Nyssen HJ; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
Acta Clin Belg; 1996; 51(6):377-85. PubMed ID: 8997755
[TBL] [Abstract][Full Text] [Related]
25. Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci.
Jetté LP; Sinave C
J Clin Microbiol; 1999 Apr; 37(4):1178-81. PubMed ID: 10074547
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics.
Marchese A; Debbia EA; Arvigo A; Pesce A; Schito GC
J Antimicrob Chemother; 1995 Nov; 36(5):833-7. PubMed ID: 8626265
[TBL] [Abstract][Full Text] [Related]
27. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.
Thomson KS; Chartrand SA; Sanders CC; Block SL
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():15-9. PubMed ID: 10404332
[TBL] [Abstract][Full Text] [Related]
28. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Barry AL; Brown SD; Novick WJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
[TBL] [Abstract][Full Text] [Related]
29. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
[TBL] [Abstract][Full Text] [Related]
30. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
31. Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2003 Oct; 47(2):435-40. PubMed ID: 14522519
[TBL] [Abstract][Full Text] [Related]
32. Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
Pottumarthy S; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):147-50. PubMed ID: 15698723
[TBL] [Abstract][Full Text] [Related]
33. Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae.
Pottumarthy S; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):345-9. PubMed ID: 17141459
[TBL] [Abstract][Full Text] [Related]
34. Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001).
Jones RN; Mutnick AH; Varnam DJ
J Clin Microbiol; 2002 Nov; 40(11):4332-3. PubMed ID: 12409423
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
Barry AL; Brown SD; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
Antimicrob Agents Chemother; 2008 Nov; 52(11):4209-10. PubMed ID: 18725443
[No Abstract] [Full Text] [Related]
37. Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics.
Bosley GS; Elliott JA; Oxtoby MJ; Facklam RR
Diagn Microbiol Infect Dis; 1987 May; 7(1):21-7. PubMed ID: 3691031
[TBL] [Abstract][Full Text] [Related]
38. In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group.
Biedenbach DJ; Johnson DM; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):325-31. PubMed ID: 10668592
[TBL] [Abstract][Full Text] [Related]
39. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
Sahm DF; Thornsberry C; Mayfield DC; Jones ME; Karlowsky JA
J Clin Microbiol; 2002 Feb; 40(2):669-74. PubMed ID: 11825993
[TBL] [Abstract][Full Text] [Related]
40. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
Esposito S; Noviello S; Ianniello F
Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
